Category Archives: PC3 and DU145

Oleandrin

Cancer: Prostate, glioma, melanoma

Action: Radio-sensitizer

Anvirzel is an extract of Nerium oleander (L.) currently undergoing, as Anvirzelª Phase I clinical evaluation as a potential treatment for cancer. Two of the active components of Anvirzel are the cardiac glycosides, oleandrin and oleandrigenin.

Prostate Cancer

In continuing research on the anti-tumor activity of this novel plant extract, the relative abilities of oleandrin and oleandrigenin to inhibit FGF-2 export from two human prostate cancer cell lines, DU145 and PC3, were examined. An ELISA assay was utilized to determine the FGF-2 concentration in the cell culture medium before and after exposure to cardiac glycosides or the parent extract material Anvirzel.

Studies also were conducted with Anvirzel (a hot water extract of Nerium oleander, known as Anvirzelª) and ouabain (found in the ripe seeds of African plants Strophanthus gratus). Oleandrin (0.1 ng/mL) produced a 45.7% inhibition of FGF-2 release from PC3 cells and a 49.9% inhibition from DU145 cells. Non-cytotoxic concentrations (100 ng/mL) of Anvirzel produced a 51.9% and 30.8% inhibition of FGF-2 release, respectively, in the two cell lines. These results demonstrate that Anvirzel, like oleandrin, inhibited FGF-2 export in vitro from PC3 and DU145 prostate cancer cells in a concentration- and time-dependent fashion and may, therefore, contribute to the anti-tumor activity of this novel treatment for cancer (Smith et al., 2001).

Radio-sensitizers; Prostate Cancer

In the present study Nasu et al. (2002) explored the relative radio-sensitization potential of oleandrin, a cardiac glycoside contained within the plant extract known as Anvirzelª. The data show that oleandrin produces an enhancement of sensitivity of PC-3 human prostate cells to radiation; at a cell survival of 0.1, the enhancement factor was 1.32. The magnitude of radio-sensitization depended on duration of exposure of cells to drug prior to radiation treatment.

While a radio-sensitizing effect of oleandrin was evident with only 1 hour of cell exposure to drug, the effect greatly increased with 24 hours of oleandrin pre-treatment.

Activation was greatest when cells were exposed simultaneously to oleandrin and radiation. Inhibition of caspase-3 activation with Z-DEVD-FMK abrogated the oleandrin-induced enhancement of radiation response suggesting that both oleandrin and radiation share a caspase-3 dependent mechanism of apoptosis in the PC-3 cell line.

Glioma, Melanoma

Twelve human tumor cell lines were chosen to examine determinants of human tumor cell sensitivity to cardiac glycosides. In vitro cell culture models of human glioma HF U251 and U251 cells as well as human parental and modified melanoma BRO cells were also included in these studies. Cardiac glycosides such as oleandrin, ouabain and bufalin increased expression of Na+, K+ -ATPase alpha 1 and therefore total Na+, K+ -ATPase activity, which is associated with increased cellular levels of glutathione. Additionally, an increased colony-forming ability was noted in cells with high levels of Na+, K+ -ATPase alpha 1 expression, suggesting that Na+, K+ -ATPase alpha 1 isoform may be actively involved in tumor growth and cell survival (Lin, Ho, & Newman, 2010)

References

Lin Y, Ho DH, Newman RA. (2010). Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+ -ATPase subunitst. J Exp Ther Oncol, 8(4):271-86.


Nasu S, Milas L, Kawabe S, Raju U, Newman R. (2002). Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process. Cancer Letters, 185(2):145–151. doi:10.1016/S0304-3835(02)00263-X


Smith JA, Madden T, Vijjeswarapu M, Newman RA. (2001). Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by anvirzel and its cardiac glycoside component, oleandrin. Biochemical Pharmacology, 62(4):469-472. doi:10.1016/S0006-2952(01)00690-6.

Sulforaphane

Cancer: Breast cancer, prostate cancer

Action: Anti-metastastatic

Prostate Cancer

Sulforaphane is isolated from varieties of broccoli and other edible cruciferous vegetables as well as the root of Angelica sinensis (Oliv.) Diels (abbreviated as AS) (Danggui), which has a long history in Asian herbal medicine. A major constituent of Angelica sinensis, sulforaphane, is also found in cruciferous vegetables. It inhibits myostatin and increases cell viability in skeletal muscle satellite cells (Alway et al., 2002).

There is preclinical evidence that oral administration of D,L-sulforaphane (SFN) can decrease the incidence or burden of early-stage prostate cancer (PIN) and well-differentiated cancer (WDC), but not late-stage poorly differentiated cancer (PDC). SFN treatment caused in vivo autophagy as evidenced by transmission electron microscopy. Mechanistic studies showed that prevention of prostate cancer and metastasis by the SFN+CQ was associated with decreased cell proliferation, increased apoptosis, alterations in protein levels of autophagy regulators Atg5 and phospho-mTOR, and suppression of biochemical features of epithelial-mesenchymal transition. Plasma proteomics identified protein expression signature that may serve as biomarker of SFN+CQ exposure/response (Vyas et al., 2013a).

Exposure of PC-3 and DU145 human prostate cancer cells to D,L-Sulforaphane (SFN) resulted in induction of vimentin protein, which was accompanied by down-regulation of E-cadherin protein expression. The SFN-mediated induction of vimentin was also observed in a normal human prostate epithelial cell line. RNA interference of vimentin did not have any appreciable effect on early or late apoptosis resulting from SFN exposure.

On the other hand, SFN-mediated inhibition of PC-3 and DU145 cell migration was significantly augmented by knockdown of the vimentin protein. Knockdown of vimentin itself was inhibitory against cell migration. The SFN-treated cells also exhibited induction of PAI-1, which is an endogenous inhibitor of urokinase-type plasminogen activator system (Vyas & Singh, 2013b).

References

Alway SE, Degens H, Lowe DA, Krishnamurthy G. (2002). Increased myogenic repressor Id mRNA and protein levels in hindlimb muscles of aged rats. Am J Physiol Regul Integr Comp Physiol, 282(2):R411-22.


Totušek J, Tříska J, Lefnerová D, et al. (2011). Contents of Sulforaphane and Total Isothiocyanates, Antimutagenic Activity, and Inhibition of Clastogenicity in Pulp Juices from Cruciferous Plants. Czech J. Food Sci, 29(5): 548–556.


Vermeulen M, Klšpping-Ketelaars IW, van den Berg R, Vaes WH. (2008). Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J Agric Food Chem, 56(22):10505-9.


Vyas AR, Hahm E-R, Arlotti JA, et al. (2013a). Chemoprevention of Prostate Cancer by D,L-Sulforaphane Is Augmented by Pharmacological Inhibition of Autophagy. Cancer Research, 73(17). doi: 10.1158/0008-5472.CAN-13-0755


Vyas AR, Singh SV. (2013b). Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells. Eur J Nutr..